1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow AIM ImmunoTech Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome Ampligen - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 3 | Completed | AIM ImmunoTech Inc. | 234 | 1998-12-01 | 2013-04-17 |